Body Vision Medical

Body Vision Medical is a medical device company based in New York City, founded in 2014. The company specializes in AI-driven, real-time intraoperative imaging solutions aimed at improving early lung cancer diagnosis and intervention. Its flagship product, LungVision®, transforms conventional 2D X-ray C-arm images into real-time 3D images using proprietary artificial intelligence technology. This innovation allows pulmonologists and thoracic surgeons to visualize and biopsy small, hard-to-reach lung lesions with enhanced accuracy during bronchoscopy procedures. The LungVision system addresses the challenge of CT-to-body divergence, significantly improving diagnostic yield from typical rates of 55-75% to around 90% or higher. It also reduces radiation exposure compared to traditional imaging methods, providing better image quality at a fraction of the radiation dose. Clinically validated in over 1,500 procedures across leading lung centers in the U.S., Israel, and Europe, Body Vision Medical's technology demonstrates superior clinical outcomes and benefits for healthcare providers and patients. The company collaborates with medical professionals to refine its platform and plans to expand its offerings in lung cancer treatment.

• Employees 37
• Founded 2014
• Total Funding $28500000